化学
四氢异喹啉
丁酰胆碱酯酶
胆碱酯酶
广告
立体化学
活动站点
体外
组合化学
酶
乙酰胆碱酯酶
阿切
有机化学
生物化学
药理学
医学
作者
Joaquín Marchán-García,Eduardo Buxaderas,Dante Nicolás Stratico,Victoria Richmond,Valéria Cavallaro,Ana Paula Murray,Gabriel Radivoy,Yanina Moglie
标识
DOI:10.1016/j.bioorg.2023.107008
摘要
A series of 19 novel α-aminophosphonate-tetrahydroisoquinoline hybrids were synthesized through a cross dehydrogenative coupling reaction between N-aryl-tetrahydroisoquinolines and dialkylphosphites, using tert-butyl hydroperoxide as oxidazing agent. This simple procedure provided products with high atom economy and moderate to high yields. In vitro cholinesterase inhibitory activity of these compounds was evaluated. All the synthesized compounds showed good to excellent selective inhibition against butyrylcholinesterase. Compound 3bc was found to be the most active derivative with an IC50 of 9 nM. Molecular modelling studies suggested that the inhibitor is located in the peripheral anionic site (PAS) of the enzyme and interacts with some residue of the catalytic anionic site. Kinetic studies revealed that 3bc acts as a non-competitive inhibitor. Predicted ADME showed good pharmacokinetics and drug-likeness properties for most hybrids. Each newly synthesized compound was characterized by IR, 1H NMR, 13C NMR, 31P NMR spectral studies and also HRMS. The results of this study suggest that α-aminophosphonate-tetrahydroisoquinoline hybrids can be promising lead compounds in the discovery of new and improved drugs for the treatment of Alzheimer’s disease and related neurodegenerative disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI